A Patient with Platelet Transfusion Refractoriness

Authors

  • Wint Wint Thu Nyunt Department of Medicine, Faculty of Medicine, MAHSA University, Selangor, MALAYSIA https://orcid.org/0000-0002-2172-2374
  • Rabeya Yousuf Blood Bank Unit, Department of Diagnostic and Laboratory Services, Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur, MALAYSIA
  • S Fadilah S Abdul Wahid Pusat Terapi Sel, Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur, MALAYSIA.

DOI:

https://doi.org/10.22452/mjs.vol44sp1.6

Keywords:

Alloantibody,, platelet immunology test, platelet transfusion refractoriness, thrombocytopenia

Abstract

Platelet transfusion refractoriness is a less-than-expected increase in platelet count following platelet transfusions. We report a case of platelet transfusion refractoriness with identification of anti-HLA class I alloantibody. In patients with thrombocytopenia, even when multiple established aetiologies are present, it is essential to recognise platelet transfusion refractoriness and to perform further laboratory investigations, including platelet immunology test. This approach enables identification of additional contributing factors to thrombocytopenia and clarification of the underlying causes of platelet refractoriness, thereby guiding appropriate therapeutic strategies.

Downloads

Download data is not yet available.

References

Cohn, C. S. (2020). Platelet transfusion refractoriness: how do I diagnose and manage? Hematology 2014, the American Society of Hematology Education Program Book, 2020(1): 527-532.

Davis, K. B., Slichter, S. J. & Corash, L. (1999). Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion, 39(6): 586-592.

Hess, J. R., Trachtenberg, F. L., Assmann, S. F., Triulzi, D. J., Kaufman, R. M., Strauss, R. G., Granger, S. & Slichter, S. J. (2016). Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial. Vox sanguinis, 111(3): 281-291.

McCullough, J. (2010). Overview of platelet transfusion. Seminars in hematology, 47(3): 235-242.

Slichter, S. J., Davis, K., Enright, H., Braine, H., Gernsheimer, T., Kao, K. J., Kickler, T., Lee, E., McFarland, J., McCullough, J., Rodey, G., Schiffer, C. A. & Woodson, R. (2005). Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood, 105(10): 4106-4114.

Trial to Reduce Alloimmunization to Platelets Study Group. (1997). Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine, 337(26): 1861-1870.

Graphical abstract

Downloads

Published

12-12-2025

How to Cite

Wint Wint Thu Nyunt, Rabeya Yousuf, & S Fadilah S Abdul Wahid. (2025). A Patient with Platelet Transfusion Refractoriness. Malaysian Journal of Science (MJS), 44(sp1), 39–42. https://doi.org/10.22452/mjs.vol44sp1.6